I founded my healthcare technology company, ClickMedix, while I was a graduate student at MIT’s Development Ventures class. Our mission is to improve the health of over one billion people. We currently have deployments in 18 countries, and serve more than a quarter million patients – all without investor money. I have been funding my startup by winning business plan competitions and through paying customers. Here are three steps to winning business plan competitions:
The Secretary of Health in Pennsylvania will leave the state to join the executive team at Geisinger Health System.
Karen Murphy, R.N., Ph.D., has been named executive vice president, chief innovation officer and founding director of Geisinger’s Steele Institute for Healthcare Innovation. Her last day with the state is Friday but she won’t start her new job at Geisinger until September.
On March 7- 8, 2017, Defined Health convened the 28th annual Cancer Progress meeting in New York City. Since 1985, Cancer Progress has served as a unique forum for an insightful and frank discussion about the scientific progress being made in oncology from the perspectives of clinical, regulatory, commercial, payer, patient advocacy, and investor stakeholders. As a companion piece to the meeting (or a primer for those who were unable to attend), the following summarizes some key takeaways and their implications for those looking to establish or maintain relevance in this fast-paced competitive landscape. Key issues addressed herein include the emerging roles of immuno-oncology (IO) vs. non-IO therapies, collaboration vs. competition, and value vs. unmitigated pricing within the evolving oncology landscape. The report closes with some thoughts about where cancer management may be going based on an assessment of present trends.
emocha Mobile Health, a Baltimore-based startup company focused on medication adherence, today announced that it has been awarded a Small Business Innovation Research award by the National Institute on Drug Abuse (NIDA). Through the NIH Fast-Track mechanism, the Phase 1 award will total $225,000, with an additional $1.5 million for Phase 2 granted upon achieving milestones. The project will demonstrate the feasibility of video directly observed therapy for patients undergoing the initiation phase of buprenorphine treatment through office-based opioid treatment (OBOT) programs. Outcomes of interest will include adherence, retention in care, measures of illicit opioid use and abstinence, and medication diversi
The National Institutes of Health has named two biological engineering researchers as winners in Phase 2 of its Follow that Cell Challenge. The winners will share $400,000 in prizes awarded for development of new tools and methods for predicting the behavior and function of a single cell in complex tissue over time – and how that reflects the health of the tissue. They were chosen from among several Phase 1 finalists.
New Enterprise Associates, Venrock, and Pelion Venture Partners—all early investors in Internet company Cloudflare—are now ponying up $100 million to fund startups that build applications atop Cloudflare’s technology, which speeds up web site performance and offers security to web applications. Cloudflare products handle an estimated 10% of the world’s web requests. If you click on a browser button, theres a good chance Cloudflare is expediting the response.
Funding and Research Opportunities
The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:
Notices
The National Institutes of Health (NIH) is by far the principal nonprofit funder of biomedical research in the United States. Consequently, when President Donald Trump’s fiscal year 2018 budget proposal included deep cuts in funding for the NIH, it sent shock waves through academic medical institutions that benefit from NIH research moneys. Although Congress is unlikely to accommodate this proposal, the suggested cuts raise the question of the role of government in medical innovation.
Whether you’re a fan of Steve Jobs and his products or not, two things are undeniable: He was very successful and very different. Now you can relax; this short article will not provide a blow-by-blow account of the man and his methods. “What would Steve Jobs tell the pharma/biotech industry?” is just a metaphor to encourage our industry to radically change — not by reinventing the wheel, but by copying the success of others.
The University System of Maryland was ranked 27th by the National Academy of Inventors and the Intellectual Property Owners Association on a list of the most U.S. patents granted last year among universities worldwide.
The University of Maryland received 48 of the 72 patents granted to universities in the university system in 2016, said Felicia Metz, the intellectual property assistant director of this university’s Office of Technology Commercialization, which works with patents owned by the university and inventors to help make the products of research available on the market.
